Hydroxyapatite
7
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
Clinical Efficacy of Vector Paro With Hydroxyapatite in the Supportive Therapy of Periodontitis
Clinical Study of Implants With Modified Surface Treatment
CRYSTALILLE Cohort: Getting the Whole Picture of Crystal-related Arthropathies
Caries-preventing Effect of a Hydroxyapatite-toothpaste in Adults
Study of People's Profile Living in France Who Could be Interested in the Use of a Nanohydroxyapatite Toothpaste
Biphasic Calcium Phosphate vs. Hydroxyapatite in Sinus Floor Elevation
Hydroxyapatite-toothpaste and Enamel Caries in the Primary Dentition